These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 26058841)
1. More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk. Rosenthal SL; Bamne MN; Wang X; Berman S; Snitz BE; Klunk WE; Sweet RA; Demirci FY; Lopez OL; Kamboh MI Neurobiol Aging; 2015 Aug; 36(8):2443.e21-6. PubMed ID: 26058841 [TBL] [Abstract][Full Text] [Related]
2. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study. Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170 [TBL] [Abstract][Full Text] [Related]
3. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge. Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275 [TBL] [Abstract][Full Text] [Related]
4. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant. Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412 [TBL] [Abstract][Full Text] [Related]
5. TREM2 variants in Alzheimer's disease. Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J; N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934 [TBL] [Abstract][Full Text] [Related]
6. Variant of TREM2 associated with the risk of Alzheimer's disease. Jonsson T; Stefansson H; Steinberg S; Jonsdottir I; Jonsson PV; Snaedal J; Bjornsson S; Huttenlocher J; Levey AI; Lah JJ; Rujescu D; Hampel H; Giegling I; Andreassen OA; Engedal K; Ulstein I; Djurovic S; Ibrahim-Verbaas C; Hofman A; Ikram MA; van Duijn CM; Thorsteinsdottir U; Kong A; Stefansson K N Engl J Med; 2013 Jan; 368(2):107-16. PubMed ID: 23150908 [TBL] [Abstract][Full Text] [Related]
8. The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans. Xiang X; Piers TM; Wefers B; Zhu K; Mallach A; Brunner B; Kleinberger G; Song W; Colonna M; Herms J; Wurst W; Pocock JM; Haass C Mol Neurodegener; 2018 Sep; 13(1):49. PubMed ID: 30185230 [TBL] [Abstract][Full Text] [Related]
9. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia. Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J; Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969 [TBL] [Abstract][Full Text] [Related]
10. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease. Lill CM; Rengmark A; Pihlstrøm L; Fogh I; Shatunov A; Sleiman PM; Wang LS; Liu T; Lassen CF; Meissner E; Alexopoulos P; Calvo A; Chio A; Dizdar N; Faltraco F; Forsgren L; Kirchheiner J; Kurz A; Larsen JP; Liebsch M; Linder J; Morrison KE; Nissbrandt H; Otto M; Pahnke J; Partch A; Restagno G; Rujescu D; Schnack C; Shaw CE; Shaw PJ; Tumani H; Tysnes OB; Valladares O; Silani V; van den Berg LH; van Rheenen W; Veldink JH; Lindenberger U; Steinhagen-Thiessen E; ; Teipel S; Perneczky R; Hakonarson H; Hampel H; von Arnim CAF; Olsen JH; Van Deerlin VM; Al-Chalabi A; Toft M; Ritz B; Bertram L Alzheimers Dement; 2015 Dec; 11(12):1407-1416. PubMed ID: 25936935 [TBL] [Abstract][Full Text] [Related]
11. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease. Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991 [TBL] [Abstract][Full Text] [Related]
12. The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk. Hooli BV; Parrado AR; Mullin K; Yip WK; Liu T; Roehr JT; Qiao D; Jessen F; Peters O; Becker T; Ramirez A; Lange C; Bertram L; Tanzi RE Neurology; 2014 Oct; 83(15):1353-8. PubMed ID: 25186855 [TBL] [Abstract][Full Text] [Related]
13. Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study. Gonzalez Murcia JD; Schmutz C; Munger C; Perkes A; Gustin A; Peterson M; Ebbert MT; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Kauwe JS Neurobiol Aging; 2013 Dec; 34(12):2889.e11-3. PubMed ID: 23855982 [TBL] [Abstract][Full Text] [Related]
14. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains. Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626 [TBL] [Abstract][Full Text] [Related]
15. Differential splicing of neuronal genes in a Trem2*R47H mouse model mimics alterations associated with Alzheimer's disease. Pandey RS; Kotredes KP; Sasner M; Howell GR; Carter GW BMC Genomics; 2023 Apr; 24(1):172. PubMed ID: 37016304 [TBL] [Abstract][Full Text] [Related]
16. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K; Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542 [TBL] [Abstract][Full Text] [Related]
17. Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes. Olive C; Ibanez L; Farias FHG; Wang F; Budde JP; Norton JB; Gentsch J; Morris JC; Li Z; Dube U; Del-Aguila J; Bergmann K; Bradley J; Benitez BA; Harari O; Fagan A; Ances B; Cruchaga C; Fernandez MV J Alzheimers Dis; 2020; 77(4):1469-1482. PubMed ID: 32894242 [TBL] [Abstract][Full Text] [Related]
18. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia. Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042 [TBL] [Abstract][Full Text] [Related]
19. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes. Thelen M; Razquin C; Hernández I; Gorostidi A; Sánchez-Valle R; Ortega-Cubero S; Wolfsgruber S; Drichel D; Fliessbach K; Duenkel T; Damian M; Heilmann S; Slotosch A; Lennarz M; Seijo-Martínez M; Rene R; Kornhuber J; Peters O; Luckhaus C; Jahn H; Hüll M; Rüther E; Wiltfang J; Lorenzo E; Gascon J; Lleó A; Lladó A; Campdelacreu J; Moreno F; Ahmadzadehfar H; ; Fortea J; Indakoetxea B; Heneka MT; Wetter A; Pastor MA; Riverol M; Becker T; Frölich L; Tárraga L; Boada M; Wagner M; Jessen F; Maier W; Clarimón J; López de Munain A; Ruiz A; Pastor P; Ramirez A Neurobiol Aging; 2014 Nov; 35(11):2657.e13-2657.e19. PubMed ID: 25042114 [TBL] [Abstract][Full Text] [Related]
20. Lack of association between triggering receptor expressed on myeloid cells 2 polymorphism rs75932628 and late-onset Alzheimer's disease in a Chinese Han population. Wang P; Guo Q; Zhou Y; Chen K; Xu Y; Ding D; Hong Z; Zhao Q Psychiatr Genet; 2018 Feb; 28(1):16-18. PubMed ID: 29256968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]